ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CONR Conor Medsystems

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Conor Medsystems NASDAQ:CONR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Conor Medsystems Third Quarter 2006 Financial Results Conference Call

02/11/2006 1:30pm

PR Newswire (US)


Conor Medsystems (NASDAQ:CONR)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Conor Medsystems Charts.
MENLO PARK, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) today announced that its third quarter 2006 financial results will be released Wednesday, November 8, 2006 after the market close and will be followed by a conference call at 5:00 PM Eastern time. Frank Litvack, M.D., Chairman and Chief Executive Officer, and Michael Boennighausen, Chief Financial Officer, will discuss the company's operating and financial results and provide updates on the company's commercialization efforts, clinical trials, product development activities, litigation and other business matters. To access the live audio broadcast or the subsequent archived recording, visit the webcast section of the company's website located at http://www.conormed.com/. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. A replay of the web cast will remain at this location until such time as the company reports its financial results for the fourth quarter of 2006. The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com/ and institutional investors can access the call via http://www.streetevents.com/ . The dial-in number for the conference call is 800-901-5217 in the U.S., 617-786-2964 outside the U.S., and the participant passcode is 45404076. About Conor Medsystems Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit http://www.conormed.com/ . DATASOURCE: Conor Medsystems, Inc. CONTACT: investors, Michael Boennighausen, Chief Financial Officer of Conor Medsystems, +1-650-614-4100, or media, Karen L. Bergman of BCC Partners, +1-650-575-1509, for Conor Medsystems Web site: http://www.conormed.com/

Copyright

1 Year Conor Medsystems Chart

1 Year Conor Medsystems Chart

1 Month Conor Medsystems Chart

1 Month Conor Medsystems Chart